Navigation Links
Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
Date:9/13/2010

hed that starting with cohort 2, PCI-32765 fully occupied the target kinase. Examining response in fully occupied dose cohorts the response rate ("RR") was 56% in the evaluable patient population and 48% in the ITT patient population. Including disease control in the form of stable disease in our assessment of evaluable patients, the disease control rate was 78% (10% CRs, 41% PRs and 27% SDs). Of note, the median tumor reduction from base line in our objective responding patients was 75% as of August 31, 2010.  
  • As of August 31, 2010, 23 patients continue to remain on study. This compares with 25 patients on study as of the ASCO presentation on June 4, 2010.  Median duration of response has not yet been determined in this ongoing study. The company has submitted an abstract describing the duration of response to the American Society of Hematology (ASH) in Orlando, FL on December 4-7, 2010; consistent with ASH's guidelines, we will not be disclosing these data prior to our ASH presentation.
  • PCI-32765 appears to be well tolerated through the initial exposure even in its highest dosing cohort (including 12.5 mg/kg). Only 2 patients of the enrolled 47 patients have experienced a dose limiting toxicity (DLT) on this trial (drug hypersensitivity and delay in dosing due to neutropenia for 7 days). No other DLTs have been observed. Thirteen of the 47 patients had 1 or more serious adverse events, but only 2 were considered drug related by investigators.
  • As previously announced we have initiated a Phase Ib trial in CLL/SLL patients studying 2 populations. One population is relapsed or refractory patients at 420 mg (24 patients with fixed dosing). The second population is elderly naive patients at 420 mg (12 patients with fixed dosing). Enrollment commenced end of May and as of to date we have dosed 30 patients (22/24 in the 420 mg relapsed or refractory dosed arm and 8/12 elderly naive patients). Amongst all patients dosed we maintain a ben
    '/>"/>

  • SOURCE Pharmacyclics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
    2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
    3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
    4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
    5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
    6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
    7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
    8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
    9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
    10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
    11. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... --  Heska Corporation (NASDAQ: HSKA - ... advanced veterinary diagnostic and other specialty veterinary products , today ... at the 16th Annual B. Riley & Co. Investor Conference ... will be held May 12-14, 2015 at Lowes Hollywood Hotel, ... be available during the day on May 13 for one-on-one ...
    (Date:5/1/2015)... , May 1, 2015 The Institute ... 2015 health literacy award winners. The IHA Health Literacy ... make an impact on the practice of educating or ... literacy. IHA gives awards in three categories: innovative programs, ... its Health Literacy Hero award. In the ...
    (Date:5/1/2015)... , May 1, 2015  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... financial results for the third quarter fiscal year ... has scheduled a conference call that same day, ...
    Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Institute for Healthcare Advancement Announces 2015 Award Winners 2Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2
    ... Renowned biochemist Michael A. Marletta, PhD, has been named by ... The Scripps Research Institute, effective January 1, 2012. He will ... institution for 25 years. Image available at: ... Chair of the Department of Chemistry, Co-Director of the Chemical ...
    ... Calif., Feb. 25, 2011 As a world leader ... prostate cancer, the Smilow Comprehensive Prostate Cancer Center ( ... Medical Center is the first medical facility in the ... navigation system for prostate biopsy that is manufactured by ...
    Cached Medicine Technology:The Scripps Research Institute Names Michael A. Marletta as President 2The Scripps Research Institute Names Michael A. Marletta as President 3The Scripps Research Institute Names Michael A. Marletta as President 4The Smilow Comprehensive Prostate Cancer Center Installs Eigen ei-Nav|Artemis™ 2The Smilow Comprehensive Prostate Cancer Center Installs Eigen ei-Nav|Artemis™ 3
    (Date:5/3/2015)... Burnsville MN (PRWEB) May 03, 2015 ... in workplace safety solutions, announces its appearance at the ... Health Conference. Products that HealthPostures will exhibit at the ... Largest of the sit stand solutions is the 6100 ... push button height control, an adjustable keyboard tray, extended ...
    (Date:5/2/2015)... Ticket Down has secured additional inventories of ... awaited event today, Saturday, May 2nd at the MGM Grand ... be able to secure tickets for both the actual fight ... fans have wanted for more than five years was finally ... will step inside the ring to fight Manny “Pac-Man” Pacquiao ...
    (Date:5/2/2015)... “ ActOn ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... make a difference. , In this material world, almost everything ... about money, which is why those things should be prioritized ...
    (Date:5/2/2015)... May 02, 2015 It’s a pattern ... natural disaster strikes anywhere on this planet, cyber scammers ... sympathy and compassion for their own personal gain. ... Emergency Readiness Team) issued an alert titled “Nepal ... email scams citing the earthquake in Nepal. The scam ...
    (Date:5/2/2015)... “ Peachtree Audio ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Scott ... conducted the review and shared with viewers how this ... an important part of people’s lives – and as ... treatment. Peachtree Audio does just that with high-end audio ...
    Breaking Medicine News(10 mins):Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2
    ... health researchers are warning that some of the most important ... yet this issue is unlikely to be given much attention ... Dr Lisa Page and Dr Louise Howard from the ... range of recent research by scientists into the potential mental ...
    ... ... nationwide honors to several deserving recipients during its national meeting in Atlanta. , ... (PRWEB) December 3, 2009 ... its national meeting on Nov. 20 in Atlanta. The honorees are as follows: ...
    ... ... pressure as well as increase the risk of obesity. Treadmill desks have been show ... , ... (Vocus) December 3, 2009 -- Two sleep studies illustrating the negative effects of sleep ...
    ... , , YOUNGTOWN, Ariz., Dec. ... announced today that it has acquired SunView Care Center, an ... sister community adjacent to Arizona,s Sun City retirement community. The ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , "We are pleased to be adding ...
    ... MINNEAPOLIS, Dec. 3 The American Association of Poison Control ... Minnesota as an accredited poison control center - a major ... places the Hennepin Regional Poison Center among 58 accredited poison ... accomplishment. It means we have met the national standards of ...
    ... , WASHINGTON, Dec. 2 In response to a ... Now ," an initiative from the U.S. Anti-Doping Agency ... leading trade association representing the dietary supplement industry, issued the following ... , President and CEO: , "We share the concerns ...
    Cached Medicine News:Health News:Major impacts of climate change expected on mental health 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4Health News:Treadmill Desks Lower Health Risks Caused by Lack of Sleep 2Health News:The Ensign Group Acquires Arizona Skilled Nursing Facility 2Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3
    ... CIC are formed as a host ... cleared by phagocytosis. If not cleared, CIC ... inflammatory response. CIC are increased in Systemic ... may be involved in other autoimmune disorders ...
    Microalbumin Linearity Control...
    The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
    ... ASO / RF / CRP ... be used as a consistent ... for monitoring the performance of ... Factor (RF), and C-Reactive Protein ...
    Medicine Products: